Parkinson's disease and risk of mortality: Meta-analysis and systematic review

Acta Neurologica Scandinavica

Volumn 129, Issue 2, 2014, Pages 71-79

  Xu, J ^a   Gong, D D ^a   Man, C F ^a   Fan, Y ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

All cause mortality; Meta analysis; Parkinson's disease

Indexed keywords

CAUSE OF DEATH; DEMENTIA; DISEASE ASSOCIATION; EMBASE; FOLLOW UP; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; PARKINSON DISEASE; PROSPECTIVE STUDY; REVIEW; SEX RATIO; SYSTEMATIC REVIEW;

ALL-CAUSE MORTALITY; META-ANALYSIS; PARKINSON'S DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK ASSESSMENT;

EID: 84891932497     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12201     Document Type: Review

References (42)

1. Dexter DT, Jenner P. Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 2013;62:132-44.
2. Damiano AM, Snyder C, Strausser B, Willian MK. A review of health-related quality-of-life concepts and measures for Parkinson's disease. Qual Life Res 1999;8:235-43.
3. Twelves D, Perkins KS, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003;18:19-31.
4. vonCampenhausen S, Bornschein B, Wick R et al. Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol 2005;15:473-90.
5. Dorsey ER, Constantinescu R, Thompson JP et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007;68:384-6.
6. Louis ED, Marder K, Cote L, Tang M, Mayeux R. Mortality from Parkinson disease. Arch Neurol 1997;54:260-4.
7. Elbaz A, Bower JH, Peterson BJ et al. Survival study of Parkinson disease in Olmsted county, Minnesota. Arch Neurol 2003;60:91-6.
8. de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM. Prognosis of Parkinson disease: risk of dementia and mortality: the rotterdam study. Arch Neurol 2005;62:1265-9.
9. D'Amelio M, Ragonese P, Morgante L et al. Long-term survival of Parkinson's disease: a population-based study. J Neurol 2006;253:33-7.
10. Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A. Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord 2006;21:1002-7.
11. Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Orwoll ES, Ensrud KE. Association of Parkinson's disease with accelerated bone loss, fractures and mortality in older men: the osteoporotic fractures in men (mros) study. Osteoporos Int 2008;19:1277-82.
12. Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology 2008;70:1423-30.
13. Posada IJ, Benito-Leon J, Louis ED et al. Mortality from Parkinson's disease: a population-based prospective study (nedices). Mov Disord 2011;26:2522-9.
14. Fall PA, Saleh A, Fredrickson M, Olsson JE, Granerus AK. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up. Mov Disord 2003;18:1312-6.
15. Morgante L, Salemi G, Meneghini F et al. Parkinson disease survival: a population-based study. Arch Neurol 2000;57:507-12.
16. Berger K, Breteler MM, Helmer C et al. Prognosis with Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the elderly research group. Neurology 2000;54:S24-7.
17. Morens DM, Davis JW, Grandinetti A, Ross GW, Popper JS, White LR. Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men. Neurology 1996;46:1044-50.
18. Ebmeier KP, Calder SA, Crawford JR, Stewart L, Besson JA, Mutch WJ. Mortality and causes of death in idiopathic Parkinson's disease: results from the aberdeen whole population study. Scott Med J 1990;35:173-5.
19. Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 2001;103:7-11.
20. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand 2004;110:118-23.
21. Duarte J, Garcia OL, Mendoza A, Claveria LE. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up). Acta Neurol Scand 2013;127:295-300.
22. Bennett DA, Beckett LA, Murray AM et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-6.
23. Henchcliffe C, Severt WL. Disease modification in Parkinson's disease. Drugs Aging 2011;28:605-15.
24. Zahodne LB, Fernandez HH. Course, prognosis, and management of psychosis in Parkinson's disease: are current treatments really effective? CNS Spectr 2008;13:26-33.
25. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA 2000;283:2008-12.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
28. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
29. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
30. Hely MA, Morris JG, Traficante R, Reid WG, O'Sullivan DJ, Williamson PM. The Sydney multicentre study of Parkinson's disease: progression and mortality at 10 years. J Neurol Neurosurg Psychiatry 1999;67:300-7.
31. Allyson JC, Wayne MW, Wieler M, King-Jesso P, Voaklander DC. Incidence and mortality of Parkinson's disease in older Canadians. Parkinsonism Relat Disord 2012;18:327-31.
32. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. 1967. Neurology 2001;57:S11-26.
33. Aarsland D, Kurz MW. The epidemiology of dementia associated with parkinson disease. J Neurol Sci 2010;289:18-22.
34. Perez F, Helmer C, Foubert-Samier A, Auriacombe S, Dartigues JF, Tison F. Risk of dementia in an elderly population of Parkinson's disease patients: a 15-year population-based study. Alzheimer's Dement 2012;8:463-9.
35. Aarsland D, Pahlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in parkinson disease-epidemiology, mechanisms and management. Nat Rev Neurol 2011;8:35-47.
36. Levy G, Tang MX, Louis ED et al. The association of incident dementia with mortality in PD. Neurology 2002;59:1708-13.
37. Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA. Predictors of survival in patients with parkinson disease. Arch Neurol 2012;69:601-7.
38. Auyeung M, Tsoi TH, Mok V et al. Ten year survival and outcomes in a prospective cohort of new onset chinese Parkinson's disease patients. J Neurol Neurosurg Psychiatry 2012;83:607-11.
39. Poewe W. The natural history of Parkinson's disease. J Neurol 2006;253(Suppl 7):VII2-6.
40. Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson's disease. J Neurol Sci 2009;276:79-83.
41. Sathyaprabha TN, Kapavarapu PK, Pall PK, Thennarasu K, Raju TR. Pulmonary functions in Parkinson's disease. Indian J Chest Dis Allied Sci 2005;47:251-7.
42. Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson's disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry 2002;72:721-5.